VERU - ベル (Veru Inc.)

VERUのニュース

   Veru (VERU) posts narrower-than-expected loss in Q2  2020/05/13 10:52:28 news.alphastreet.com
Veru Inc. (NASDAQ: VERU) reported its financial results for the quarter ended March 31, 2020, on Wednesday before the market opens. The company posted a narrower loss for Q2 as the substantial growth in prescription sales of FC2 drove the top-line higher. On Tuesday, Veru received FDA permission to initiate a phase 2 clinical trial […]
   Veru Inc. (NASDAQ: VERU) Q1 2020 Earnings Call Transcript  2020/03/17 09:06:22 news.alphastreet.com
Veru Inc. (NASDAQ: VERU) Q1 2020 Earnings Conference Call Final Transcript CORPORATE PARTICIPANTS: Sam Fisch — Director of Investor Relations Mitchell S. Steiner — Chairman, President and Chief Executive Officer Michele Greco — Chief Financial Officer and Chief Administrative Officer ANALYSTS: Brandon Folkes — Cantor Fitzgerald — Analyst Leland Gershell — Oppenheimer — Analyst Kumar Raja — Brookline Capital Markets — Analyst Peter McMullin — Consultant — Analyst PRESENTATION: Operator […]
   Veru Inc. (VERU): Q1 2020 Earnings Snapshot  2020/02/12 13:50:41 news.alphastreet.com
— Veru Inc. (NASDAQ: VERU) reported Q1 2020 loss of $0.05 per share, vs. $0.02 expected. — Revenues grew 66% to $10.6 million, vs. $8.7…
   Short Interest in Veru Inc (NASDAQ:VERU) Increases By 36.6%  2019/11/13 09:03:26 Modern Readers
Veru Inc (NASDAQ:VERU) was the target of a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 72,100 shares, an increase of 36.6% from the September 30th total of 52,800 shares. Currently, 0.2% of the shares of the company are sold short. Based on an […]
   Options Traders Expect Huge Moves in Veru (VERU) Stock  2019/07/08 13:32:00 Zacks Investment Research
Investors need to pay close attention to Veru (VERU) stock based on the movements in the options market lately.
   Veru (VERU) posts narrower-than-expected loss in Q2  2020/05/13 10:52:28 news.alphastreet.com
Veru Inc. (NASDAQ: VERU) reported its financial results for the quarter ended March 31, 2020, on Wednesday before the market opens. The company posted a narrower loss for Q2 as the substantial growth in prescription sales of FC2 drove the top-line higher. On Tuesday, Veru received FDA permission to initiate a phase 2 clinical trial […]
   Veru Inc. (NASDAQ: VERU) Q1 2020 Earnings Call Transcript  2020/03/17 09:06:22 news.alphastreet.com
Veru Inc. (NASDAQ: VERU) Q1 2020 Earnings Conference Call Final Transcript CORPORATE PARTICIPANTS: Sam Fisch — Director of Investor Relations Mitchell S. Steiner — Chairman, President and Chief Executive Officer Michele Greco — Chief Financial Officer and Chief Administrative Officer ANALYSTS: Brandon Folkes — Cantor Fitzgerald — Analyst Leland Gershell — Oppenheimer — Analyst Kumar Raja — Brookline Capital Markets — Analyst Peter McMullin — Consultant — Analyst PRESENTATION: Operator […]
   Veru Inc. (VERU): Q1 2020 Earnings Snapshot  2020/02/12 13:50:41 news.alphastreet.com
— Veru Inc. (NASDAQ: VERU) reported Q1 2020 loss of $0.05 per share, vs. $0.02 expected. — Revenues grew 66% to $10.6 million, vs. $8.7…
   Short Interest in Veru Inc (NASDAQ:VERU) Increases By 36.6%  2019/11/13 09:03:26 Modern Readers
Veru Inc (NASDAQ:VERU) was the target of a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 72,100 shares, an increase of 36.6% from the September 30th total of 52,800 shares. Currently, 0.2% of the shares of the company are sold short. Based on an […]
   Options Traders Expect Huge Moves in Veru (VERU) Stock  2019/07/08 13:32:00 Zacks Investment Research
Investors need to pay close attention to Veru (VERU) stock based on the movements in the options market lately.
   Veru (VERU) posts narrower-than-expected loss in Q2  2020/05/13 10:52:28 news.alphastreet.com
Veru Inc. (NASDAQ: VERU) reported its financial results for the quarter ended March 31, 2020, on Wednesday before the market opens. The company posted a narrower loss for Q2 as the substantial growth in prescription sales of FC2 drove the top-line higher. On Tuesday, Veru received FDA permission to initiate a phase 2 clinical trial […]
   Veru Inc. (NASDAQ: VERU) Q1 2020 Earnings Call Transcript  2020/03/17 09:06:22 news.alphastreet.com
Veru Inc. (NASDAQ: VERU) Q1 2020 Earnings Conference Call Final Transcript CORPORATE PARTICIPANTS: Sam Fisch — Director of Investor Relations Mitchell S. Steiner — Chairman, President and Chief Executive Officer Michele Greco — Chief Financial Officer and Chief Administrative Officer ANALYSTS: Brandon Folkes — Cantor Fitzgerald — Analyst Leland Gershell — Oppenheimer — Analyst Kumar Raja — Brookline Capital Markets — Analyst Peter McMullin — Consultant — Analyst PRESENTATION: Operator […]
   Veru Inc. (VERU): Q1 2020 Earnings Snapshot  2020/02/12 13:50:41 news.alphastreet.com
— Veru Inc. (NASDAQ: VERU) reported Q1 2020 loss of $0.05 per share, vs. $0.02 expected. — Revenues grew 66% to $10.6 million, vs. $8.7…
   Short Interest in Veru Inc (NASDAQ:VERU) Increases By 36.6%  2019/11/13 09:03:26 Modern Readers
Veru Inc (NASDAQ:VERU) was the target of a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 72,100 shares, an increase of 36.6% from the September 30th total of 52,800 shares. Currently, 0.2% of the shares of the company are sold short. Based on an […]
   Options Traders Expect Huge Moves in Veru (VERU) Stock  2019/07/08 13:32:00 Zacks Investment Research
Investors need to pay close attention to Veru (VERU) stock based on the movements in the options market lately.

calendar